US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Core High Dividend ETF

27.95

+0.30001.08%

Post-market: 27.990.0369+0.13%19:47 EDT

Volume:2.15M

Turnover:59.98M

Market Cap:13.75B

PE:- -

High:28.00

Open:27.74

Low:27.73

Close:27.65

52wk High:28.18

52wk Low:22.83

Shares:491.90M

Float Shares:491.90M

Volume Ratio:0.78

T/O Rate:0.44%

Dividend:0.79

Dividend Rate:2.83%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

FDA approves Gilead’s Hepcludex injection to treat chronic HDV infection

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference

Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights

Mirum’s brelovitug succeeds in Phase 2b HDV trial

Meet the Next Generation of Dividend Aristocrats

The Iran War Could Drag On. Where Investors Are Finding Winners Now. -- Barrons.com

Press Release: Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights

Retiring Soon? Why the HDV ETF Beats DVY for Steady 2026 Income

DGRO vs. HDV: Which BlackRock iShares Dividend ETF Pays More Income?

DGRO, DVY, and HDV: 3 iShares Dividend ETFs to Watch Now

Libevitug Approved in China as First-in-Class Hepatitis D Treatment

Vir Biotechnology: Strengthening Best-in-Class HDV Profile with Robust SOLSTICE Data, Strategic Partnerships, and Sufficient Cash Runway Supporting Buy Rating

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HDV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HDV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HDV\",,,,,undefined,":{"symbol":"HDV","market":"US","secType":"STK","nameCN":"iShares Core High Dividend ETF","latestPrice":27.95,"timestamp":1779480000000,"preClose":27.65,"halted":0,"volume":2148928,"hourTrading":{"tag":"盘后","latestPrice":27.9869,"preClose":27.95,"latestTime":"19:47 EDT","volume":4703,"amount":131358.4118,"timestamp":1779493673349,"change":0.0369,"changeRate":0.00132,"amplitude":0.01098},"delay":0,"changeRate":0.010849909584086825,"floatShares":491900000,"shares":491900000,"eps":0,"marketStatus":"Market Closed","change":0.3,"latestTime":"05-22 16:00:00 EDT","open":27.74,"high":28,"low":27.73,"amount":59977728.007552,"amplitude":0.009765,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":27.65,"sharesOutstanding":98450000,"nav":27.644407,"aum":13602430464.35,"dividendRate":0.028326,"bidAskSpread":0.000364,"preHourTrading":{"tag":"盘前","latestPrice":27.5,"preClose":27.65,"latestTime":"09:20 EDT","volume":457,"amount":12602.110895000002,"timestamp":1779456051443,"change":-0.15,"changeRate":-0.005425,"amplitude":0.014358},"postHourTrading":{"tag":"盘后","latestPrice":27.9869,"preClose":27.95,"latestTime":"19:47 EDT","volume":4703,"amount":131358.4118,"timestamp":1779493673349,"change":0.0369,"changeRate":0.00132,"amplitude":0.01098},"volumeRatio":0.7792483950132533,"impliedVol":0.1794,"impliedVolPercentile":0.9323},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HDV\",,,,,undefined,":{"symbol":"HDV","floatShares":491900000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7792483950132533,"shares":491900000,"dividePrice":0.791702,"high":28,"amplitude":0.009765,"preClose":27.65,"low":27.73,"week52Low":22.825,"pbRate":"--","week52High":28.178,"institutionHeld":0,"latestPrice":27.95,"eps":0,"divideRate":0.028326,"volume":2148928,"delay":0,"ttmEps":0,"open":27.74,"prevYearClose":24.322,"prevWeekClose":27.3,"prevMonthClose":27.47,"prevQuarterClose":27.144,"fiveDayClose":27.3,"twentyDayClose":26.804,"sixtyDayClose":27.684},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HDV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-04-29","symbol":"HDV","defaultRemindTime":1777469400000,"type":"split","dateTimestamp":1777435200000,"forFactor":1,"toFactor":5,"ratio":0.2},{"date":"2026-03-17","symbol":"HDV","amount":0.842962,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"HDV","amount":1.25288,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"HDV","amount":0.949579,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-06-16","symbol":"HDV","amount":0.91309,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares High Dividend Equity Fun","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HDV\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-21","recordDate":"2016-06-23","paymentDate":"2016-06-27","value":0.679421,"currency":"USD"},{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.687623,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.655685,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.7228843,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.718133,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HDV\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HDV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637346085","title":"FDA approves Gilead’s Hepcludex injection to treat chronic HDV infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2637346085","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637346085?lang=en_us&edition=fundamental","pubTime":"2026-05-23 01:25","pubTimestamp":1779470743,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration approved Hepcludex injection to treat chronic hepatitis delta virus infection in adults without cirrhosis or ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fda-approves-gileads-hepcludex-injection-to-treat-chronic-hdv-infection-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fda-approves-gileads-hepcludex-injection-to-treat-chronic-hdv-infection-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HDV","BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637163903","title":"Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2637163903","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637163903?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:00","pubTimestamp":1779447600,"startTime":"0","endTime":"0","summary":"– Phase 2 study in cholestatic liver diseases, focused on PBC and PSC, anticipated to initiate in Q1 2027 –– Builds on completed Phase 1a study and ongoing development in HDV – SOUTH SAN FRANCISCO, Ca","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/22/3300036/16259/en/Assembly-Biosciences-Announces-Expansion-of-ABI-6250-Clinical-Development-Into-Cholestatic-Liver-Diseases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","BK4585","ABI","ASMB","HDV","PBC","PSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634864712","title":"Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2634864712","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634864712?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:00","pubTimestamp":1778500800,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., May  11, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/11/3291802/16259/en/Assembly-Biosciences-to-Present-at-the-BofA-Securities-2026-Global-Health-Care-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4581","BK4139","ASMB","LABU","HDV","BK4588","BK4585","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633176504","title":"Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2633176504","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633176504?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:00","pubTimestamp":1778184000,"startTime":"0","endTime":"0","summary":"– Completed Phase 1b studies for ABI-5366 and ABI-1179, helicase-primase inhibitors for recurrent genital herpes – – Completed chronic toxicology studies for ABI-6250, an oral small-molecule entry inh","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3290491/16259/en/Assembly-Biosciences-Reports-First-Quarter-2026-Financial-Results-and-Recent-Highlights.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","HPI","ASMB","HDV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630391653","title":"Mirum’s brelovitug succeeds in Phase 2b HDV trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2630391653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630391653?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:31","pubTimestamp":1777293110,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals ( ($MIRM) ) has issued an announcement. On April 27, 2026, Mirum reported that the Phase 2b portion of its AZURE-1 study in c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mirums-brelovitug-succeeds-in-phase-2b-hdv-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mirums-brelovitug-succeeds-in-phase-2b-hdv-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HDV","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624520827","title":"Meet the Next Generation of Dividend Aristocrats","url":"https://stock-news.laohu8.com/highlight/detail?id=2624520827","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624520827?lang=en_us&edition=fundamental","pubTime":"2026-04-02 23:30","pubTimestamp":1775143800,"startTime":"0","endTime":"0","summary":"The S&P 500 Dividend Aristocrats Index, known for its defensive traits in tough markets, has lived up to its billing this year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0072461881.USD","LU1267930573.SGD","LU2168564222.USD","LU2756315318.SGD","LU2471134952.CNY","LU0347712357.USD","IE0004091025.USD","LU1582987597.SGD","LU1620156130.USD","IE00BMPRXR70.SGD","LU0203201768.USD","LU0444973449.USD","LU1244550221.USD","HD","LU0871640123.AUD","IE00B5949003.HKD","IE0004445015.USD","SG9999014575.USD","LU1585245621.USD","BK4134","BK4581","LU2237438978.USD","LU2089985449.USD","IE0034235295.USD","LU1334329650.SGD","SGXZ31699556.SGD","LU1400636657.SGD","LU1645745479.HKD","LU1721428933.USD","LU0077335932.USD","LU1951200564.SGD","LU0006306889.USD","LU1989764664.SGD","LU0390134368.USD","LU0069063385.USD","LU2552382058.USD","LU1718418525.SGD","LU1267930490.SGD","BK4566","LU0545562505.USD","LU0661504455.SGD","LU2125909593.SGD","LU0302445910.USD","LU0203202063.USD","LU2746668461.USD","IE00B4JS1V06.HKD","LU1064131342.USD","IE00BKDWB100.SGD","IE0034235188.USD","LU1803068979.SGD","LU0276348264.USD","LU1951198990.SGD","LU1429558221.USD","BK4147","LU2279689827.SGD","LU1280957306.USD","LU1543694498.USD","LU1804176565.USD","LU1093756168.USD","LU2275660780.HKD","LU1868837136.USD","LU2092937148.SGD","LU0345774391.USD","LU1929549753.HKD","LU0889566641.SGD","LU0158827781.USD","LU0096362180.USD","LU2404859667.USD","LU0211328371.USD","LU1093756325.SGD","LU0965509283.SGD","IE00B775H168.HKD","LU1235294995.USD","LU2242649171.HKD","LU2111349929.HKD","LU1043141396.HKD","BK4504","IE00B3SWFQ91.USD","LU2097829019.USD","LU1815336760.USD","LU1582986433.USD","LU2417539215.USD","LU0353189763.USD","LU1670711123.USD","TXN","BK4516","LU0823417737.USD","LU1582986359.USD","MSFT","LU1883839398.USD","LU2896262040.SGD","IE00BN29S564.USD","LU0310799852.SGD","SG9999018865.SGD","LU1145028129.USD","BK4548","LU2077746001.SGD","LU0960925559.SGD","LU1035775433.USD","LU1935042991.SGD","LU1066051811.HKD","LU2168563687.JPY","LU2264538146.SGD","IE00BHPRN162.USD","LU2242650005.HKD","LU2237443549.SGD","SG9999015986.USD","IE00BQXX3F31.USD","LU0095938881.EUR","LU2063271972.USD","LU0210536198.USD","LU0234572021.USD","LU0476273544.USD","LU1732799900.SGD","LU2491050071.SGD","LU0289941410.SGD","LU0094547139.USD","LU1935042488.USD","LU2347655156.SGD","LU2491050154.USD","LU2237957902.USD","IE00BFXG0V08.USD","LU0795875086.SGD","SG9999018857.SGD","LU0640476718.USD","LU0994945656.USD","LU1035773651.USD","LU0029864427.USD","LU0426417589.USD","LU1236620750.USD","LU2471134796.USD","SGXZ81514606.USD","LU0210533765.USD","LU1861127337.USD","QCOM","LU0820562030.AUD","SG9999002232.USD","IE00BMPRXQ63.HKD","LU0642271901.SGD","IE00BK4W5L77.USD","LU2602419157.SGD","LU2237443895.HKD","LU1267930813.SGD","LU2065171402.SGD","LU2506952097.USD","LU2087621335.USD","LU0215105999.USD","LU0545039389.USD","LU1934455277.USD","LU0162691827.USD","LU1670628061.USD","LU0345770993.USD","LU0082616367.USD","LU0256863811.USD","LU0788109477.HKD","LU2108987350.USD","LU2237443465.HKD","LU2360108059.USD","LU1228905540.USD","LU2191332357.HKD","IE00BQXX3C00.GBP","SG9999015358.SGD","LU1983260115.SGD","LU2458330243.SGD","LU0289960550.SGD","LU1261432733.SGD","SG9999002224.SGD","LU0323239441.USD","IE00B1BXHZ80.USD","SG9999015341.SGD","LU0320765646.SGD","DGRW","SG9999014906.USD","LU2750360997.AUD","LU2746668974.SGD","IE00BMPRXN33.USD","LU0823417653.USD","LU2404859741.USD","LU1162221912.USD","IE00B3S45H60.SGD","LU2028103732.USD","LU2357305700.SGD","LU2360106780.USD","LU2250418816.HKD","BK4528","LU1720051017.SGD","LU2168564495.EUR","DGRO","BK4588","SG9999004303.SGD","LU0726765562.USD","LU1084165304.USD","IE00BBT3K403.USD","LU2089283258.USD","LU1989772923.USD","LU0128525929.USD","LU0949170426.SGD","LU1720051108.HKD","MSFX","SG9999014914.USD","LU0757359954.USD","LU2210150020.SGD","SG9999001424.SGD","LU2168564065.EUR","LU0557290698.USD","LU0738911758.USD","LU0011850046.USD","LU0210528500.USD","LU0784383803.USD","LU0868494617.USD","IE00BKVL7J92.USD","LU0289739343.SGD","LU2764262908.HKD","IE00BN8TJ469.HKD","LU1721428347.USD","LU0708995401.HKD","LU0757359368.USD","LU1894683264.USD","IE000ITXATA3.USD","IE0005OL40V9.USD","LU2360032135.SGD","SDIV","SG9999001077.SGD","LU0868494708.USD","IE0001KFT4U8.USD","BK4534","BK4503","LU2298321311.HKD","LU0157215616.USD","LU1235295455.SGD","LU2095319765.USD","BK4554","LU0553294199.USD","LU0312595415.SGD","LU1778281490.HKD","LU2362541273.HKD","LU1202635105.USD","LU1037948541.HKD","LU2552382132.HKD","LU0107464264.USD","LU2456880835.USD","LU2148611432.USD","LU0310800379.SGD","LU0265550359.USD","LU1564329115.USD","IE00BJTD4V19.USD","LU1623119135.USD","LU1116320901.HKD","LU0321505868.SGD","LU1861215975.USD","LU0234570918.USD","LU0957808578.USD","LU2247934214.USD","SG9999014567.USD","LU2361044949.HKD","LU0719512351.SGD","LU2750360641.GBP","LU0266013472.USD","LU0894486033.HKD","LU1803068623.USD","LU2463028550.USD","LU1989764748.USD","LU0256863902.USD","LU2506951958.HKD","LU0158827948.USD","LU1564329032.USD","LU2361045086.USD","LU1674673428.USD","LU2210149790.SGD","BK4519","LU1003077747.HKD","LU2065169927.USD","LU0823434583.USD","LU0070217475.USD","LU1934455863.HKD","LU2360107168.USD","LU1400636491.USD","BK4587","LU2552382215.SGD","LU2362541513.USD","LU0912757837.SGD","LU2125154778.USD","HK0000914686.HKD","LU2505996681.GBP","LU1551013342.USD","LU1721427968.SGD","LU1232071149.USD","IE00BJLML261.HKD","SGXZ51526630.SGD","LU2477742899.HKD","LU0345768740.USD","IE000YTNTUN2.SGD","LU0943347566.SGD","LU2271345857.HKD","LU0342679015.USD","LU0708994859.HKD","LU0949170772.SGD","LU1236620834.HKD","LU2023251221.USD","LU0965508806.USD","LU2413666004.HKD","IE00BLSP4452.SGD","LU0882574139.USD","LU2211815571.USD","LU0057025933.USD","LU2458330169.SGD","LU0894485498.HKD","LU1069344957.HKD","LU1642822529.SGD","LVHI","IE00BJJMRY28.SGD","LU0426412945.USD","LU0792757196.USD","LU2237443978.SGD","LU0689472784.USD","LU2083900584.USD","LU0061474705.USD","KLAG","LU0942090050.USD","LU2461242641.AUD","LU0345768153.USD","SG9999015978.USD","LU1989763005.USD","LU1823568750.SGD","LU1066051225.USD","LU0061475181.USD","LU2286300806.USD","LU0187121727.USD","LU0072462426.USD","LU1670710588.SGD","LU1868836757.USD","LU2106854487.HKD","LU0354030438.USD","LU2092937221.SGD","LU0823434740.USD","IE00BZ1G4Q59.USD","LU0109391861.USD","LU1564329461.SGD","LU1868836591.USD","MSFW","LU2543165471.USD","IE00B19Z8X17.USD","BK4527","BLK","LU0238689110.USD","IE00BLSP4239.USD","LU2065171311.SGD","LU1221951129.SGD","LU2054465674.USD","LU2487616109.SGD","LU1868836914.USD","LU0175139822.USD","LU2244417387.USD","LU0690374615.EUR","LU0320765059.SGD","LU1917777945.USD","VIGI","LU0056508442.USD","LU1165135440.EUR","LU1868837300.USD","SG9999014880.SGD","LU0048584097.USD","LU1974910355.USD","LU0345769631.USD","LU2764263203.CNY","LU0964807845.USD","LU0528227936.USD","LU2430703095.HKD","LU1839511570.USD","BK4535","LU2065170008.USD","BK4525","LU2168564149.EUR","LU1430594728.SGD","LU1059921491.USD","LU0079474960.USD","LU0314106906.USD","LU1852331112.SGD","LU0265550946.USD","LU1935043536.SGD","LU1032955483.USD","LU2265009873.SGD","IE00BDCRKT87.USD","LU2092627202.USD","LU2433249047.HKD","LU2125154935.USD","BK4577","LU2347655073.USD","IE00BFSS7M15.SGD","BK4543","SG9999001440.SGD","LU1629891620.HKD","LU1914381329.SGD","IE00BJJMRX11.SGD","LU2491049909.HKD","BK4533","LU1181866309.USD","LU1032466523.USD","IE00B4YYXB79.USD","LU2236285917.USD","MSFL","SG9999014559.SGD","IE00BSNM7G36.USD","SG9999014898.SGD","MSFY","LU2413665964.HKD","LU1066051498.USD","SDY","GB00BDT5M118.USD","LU0149725797.USD","LU0957791311.USD","IE00B19Z8W00.USD","LU1989773731.SGD","UPS","LU2430703251.USD","LU2023250330.USD","LU1670711040.USD","LU0308772762.SGD","LU1791710400.SGD","LU1791710582.SGD","LU0198837287.USD","LU1815333072.USD","LU0138981039.USD","LU1188199696.SGD","KLAC","LU1323610961.USD","LU1935042215.USD","LU0211327993.USD","LU1074936037.SGD","LU0511384066.AUD","LU0494093205.USD","LU1674673691.USD","LU0154236417.USD","LU1221951046.USD","LU1228905037.USD","LU1564329628.SGD","LU0323240290.USD","LU0097036916.USD","LU1400636574.HKD","LU1127390331.HKD","LU2125909247.SGD","LU0098860793.USD","LU2087625088.SGD","LU0225283273.USD","LU0106261372.USD","LU1989772840.SGD","LU1267930730.SGD","LU2420271590.USD","IE00BDRTCR15.USD","LU0472753341.HKD","LU2592432038.USD","LU1880398471.USD","LU1712237335.SGD","IE0004445239.USD","IE00B5TLWC47.USD","LU0323591593.USD","BK4579","BK4538","LU2097344357.USD","LU2097344431.USD","SCHD","IE0004086264.USD","DVY","SG9999014542.SGD","LU0784385840.USD","LU0784384876.USD","LU2237443382.USD","LU0053666078.USD","IE00B19Z9505.USD","LU2413666699.HKD","LU0889565833.HKD","LU0354030511.USD","LU1366333091.USD","LU1116320737.USD","LU0724617625.USD","LU0950375773.USD","SGXZ23171101.USD","LU0109392836.USD","LU1435385759.SGD","LU1894683348.USD","LU0861579265.USD","IE00BK4W5M84.HKD","IE000W1ABFV2.USD","LU2023250843.SGD","LU2133065610.SGD","LU2506951875.HKD","BK4598","LU2452424414.USD","LU1691799644.USD","LU1340139317.AUD","LU1046421795.USD","LU0672654240.SGD","IE0034235303.USD","LU1571399168.USD","LU1935043023.USD","LU0096364046.USD","LU2237957811.SGD","LU0321505439.SGD","IE00BJTD4N35.SGD","LU2403377893.USD","LU0823421333.USD","LU1620156213.USD","LU2506952337.HKD","LU0985320562.USD","LU1037948897.HKD","LU0820561909.HKD","KBWD","LU2041044095.USD","LU0289961442.SGD","LU1697837992.HKD","LU0314104364.USD","LU1814569148.SGD","SGXZ99366536.SGD","LU0417517546.SGD","LU1670710661.SGD","LU2506952170.USD","BK4532","IE00BQXX3D17.EUR","LU2506952410.USD","LU2756315664.SGD","CGDV","LU1496350502.SGD","LU0689626769.HKD","LU1316542783.SGD","BK4083","SPHD","LU1069347547.HKD","IE00BKPKM429.USD","LU0348723411.USD","LU1582987324.SGD","HK0000914660.USD","LU2720916845.USD","BK4575","IE00B7KXQ091.USD","LU0795875169.SGD","SG9999015952.SGD","LU1923622614.USD","GB00B4LPDJ14.GBP","SG9999017495.SGD","LU2326559502.SGD","IE0003U64NQ7.SGD","MSFD","LU0170899867.USD","LU1923623000.USD","LU1861220033.SGD","LU1119994496.HKD","LU0345769128.USD","LU0080751232.USD","BK4567","LU0081259029.USD","LU0171293334.USD","LU0879622024.SGD","LU1732800096.USD","LU1988902786.USD","LU1548497426.USD","SPYD","SG9999000418.SGD","LU2860962120.EUR","LU2430703178.SGD","LU0456855351.SGD","GB00B4QBRK32.GBP","MSFU","LU1596574779.USD","LU2089284900.SGD","LU0820561818.USD","LU0965509101.SGD","LU2764263039.SGD","LU2237443622.USD","LU1934455194.USD","IE000KEQY171.SGD","BK4576","LU1244550577.SGD","IE00B1XK9C88.USD","LU0823411888.USD","SG9999015945.SGD","IE0009G5SDU7.USD","BK4602","LU2505996509.AUD","LU2462157665.USD","LU1496350171.SGD","LU2413666426.HKD","HDV","LU2023250504.SGD","LU1670756490.USD","LU0466842654.USD","BK4550","LU1066053197.SGD","LU1670627923.USD","LU1244550494.USD","LU1880398554.USD","IE0009356076.USD","FDVV","BK4585","LU0690374961.EUR","LU1633808545.USD","LU0345770308.USD","LU0061474960.USD","LU0267386448.USD","IE00BFSS8Q28.SGD","IE0008368304.USD","LU1301847155.USD","LU2290526834.HKD","LU0823421416.USD","LU1366192091.USD","LMT","DIVO","IE00BYQQ9H92.USD","LU0444971666.USD","IE00BYXW3230.USD","LU1506573853.SGD","IE00BWXC8680.SGD","LU1153585028.USD","LU2361044865.SGD","LU0345774631.USD","LU0965509010.AUD","LU0251132253.USD","LU1043141123.HKD","MSFO","LU2362540622.SGD","BK4612","LU0353189680.USD","LU1551013425.SGD","LU0316494557.USD","LU0784385170.HKD","LU2471134523.USD","LU0787776722.HKD","BK4592","LU2381873111.SGD","LU2471134879.HKD","LU0274383776.USD","BK4097","LU1121112475.USD","LU1196500208.SGD","LU0683600562.USD","LU0124676726.USD","IE00B775SV38.USD","LU0127658192.USD","LU2213496289.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623391633","title":"The Iran War Could Drag On. Where Investors Are Finding Winners Now. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2623391633","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623391633?lang=en_us&edition=fundamental","pubTime":"2026-03-30 15:00","pubTimestamp":1774854000,"startTime":"0","endTime":"0","summary":"The Nasdaq is in a correction, down more than 10% from its recent highs. And there are growing worries that the tech-heavy index could soon find itself in a bear market -- a drop of 20%. But you know what they say on Wall Street: There's always a bull market somewhere.Even though the broader market has pulled back in the past few days, extending their weekly losing streak to five, there were pockets of strength this past week -- and for the whole month of March, for that matter.Another legacy tech firm, albeit once trading at a much higher multiple than Dell and HPE, is also getting an AI boost. Shares of glass and optical networking leader Corning were up nearly 10% on the back of a bullish analyst report from BofA Securities. At more than 40 times earnings estimates, Corning isn't cheap. But like Dell and HPE, it's viewed as a winner in a world where tech spending isn't about to collapse anytime soon.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345781412.USD","LU0278409577.USD","LU0122376428.USD","LU0006061336.USD","LU0345770993.USD","LU2272731782.SGD","HDV","LU0321505868.SGD","SMCL","LU0985481810.HKD","IE00BFMHRM44.USD","SG9999002521.SGD","LU1280957306.USD","SMCX","IE00B7SZLL34.SGD","LU0098860793.USD","SMYY","LU2129689605.HKD","LU0265550946.USD","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0208291251.USD","LU0612318385.USD","LU1861215975.USD","LU0061475181.USD","HPE","LU1066053197.SGD","GLW","LU0256863811.USD","LU0225771236.USD","LU1883839398.USD","BK4170","LU0612318971.USD","STT","LU0868494708.USD","LU2129689431.USD","BK4512","LU2272731865.HKD","SMCY","LU0265550359.USD","CVX","ISBC","SMCZ","LU1929549753.HKD","LU0417517546.SGD","IE00B19Z3B42.SGD","BK4135","SMCC","BK4148"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2620276128","title":"Press Release: Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2620276128","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620276128?lang=en_us&edition=fundamental","pubTime":"2026-03-20 04:05","pubTimestamp":1773950700,"startTime":"0","endTime":"0","summary":"-- Successfully licensed helicase-primase inhibitor program for recurrent genital herpes to Gilead, including candidates ABI-5366 and ABI-1179, following positive Phase 1b interim data; development plan anticipated by mid-2026 --. -- Phase 2 initiation for ABI-6250, an oral small-molecule entry inhibitor candidate for chronic hepatitis delta virus, anticipated by end of 2026 --. SOUTH SAN FRANCISCO, Calif., March 19, 2026  -- Assembly Biosciences, Inc. , a biotechnology company developing innovative therapeutics targeting serious viral diseases, today reported financial results for the year ended December 31, 2025, and recent highlights.\"2025 was a pivotal year for the Company, and we anticipate another strong year ahead,\" said Jason Okazaki, chief executive officer and president of Assembly Bio. \"Compelling Phase 1b data across ABI-5366 and ABI-1179 led to an early decision by Gilead to license the HPI program, validating the strength of our science and execution, as well as the poten","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4232","BK4585","ASMB","BK4139","HPI","R","BK4022","HDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618964945","title":"Retiring Soon? Why the HDV ETF Beats DVY for Steady 2026 Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2618964945","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618964945?lang=en_us&edition=fundamental","pubTime":"2026-03-11 18:21","pubTimestamp":1773224475,"startTime":"0","endTime":"0","summary":"Income investors are constantly looking for ways to boost their portfolio’s cash flow without taking on unnecessary risk. Two of the most popular t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/retiring-soon-why-the-hdv-etf-beats-dvy-for-steady-2026-income?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/retiring-soon-why-the-hdv-etf-beats-dvy-for-steady-2026-income?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HDV","DVY","BK4588","BK4585","BK4550","FDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617659329","title":"DGRO vs. HDV: Which BlackRock iShares Dividend ETF Pays More Income?","url":"https://stock-news.laohu8.com/highlight/detail?id=2617659329","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617659329?lang=en_us&edition=fundamental","pubTime":"2026-03-07 08:30","pubTimestamp":1772843418,"startTime":"0","endTime":"0","summary":"Investors looking for dividend income often compare BlackRock’s ($BLK) iShares Core Dividend Growth ETF ($DGRO) and iShares Core High Dividend ETF ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/dgro-vs-hdv-which-blackrock-ishares-dividend-etf-pays-more-income?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/dgro-vs-hdv-which-blackrock-ishares-dividend-etf-pays-more-income?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0731783394.SGD","LU0640476718.USD","LU1064131342.USD","LU1670628061.USD","BK4588","LU1988902786.USD","BLK","LU2430703251.USD","BK4135","BK4567","IE00B64PRP62.GBP","BK4581","IE00B3QW5Z07.USD","LU1280957306.USD","LU0731783048.USD","LU0742537680.HKD","LU0980610538.SGD","HDV","LU1074936037.SGD","IE00BVYPNW00.USD","LU1481011671.HKD","LU1201861249.SGD","DGRO","LU2430703178.SGD","SCHD","IE00BDGV0183.EUR","LU1599440770.SGD","LU1989771016.USD","LU0157215616.USD","LU2505996681.GBP","BK4535","IE00BVYPNV92.GBP","LU0648001328.SGD","BK4533","FDN","BK4550","LU1509826696.USD","BK4504","LU1291159041.SGD","BK4534","LU2264538146.SGD","LU0070302665.USD","LU0320765489.SGD","BK4585","LU0772969993.USD","IE00B42XCP33.USD","IE00BGHQF748.EUR","IE00BGHQF631.EUR","LU1481011911.USD","LU0130102774.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610851608","title":"DGRO, DVY, and HDV: 3 iShares Dividend ETFs to Watch Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2610851608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610851608?lang=en_us&edition=fundamental","pubTime":"2026-02-11 08:11","pubTimestamp":1770768691,"startTime":"0","endTime":"0","summary":"BlackRock’s ($BLK) iShares lineup offers several ways to earn dividend income, but not all dividend ETFs are built the same. The iShares Core Divid...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/dgro-dvy-and-hdv-3-ishares-dividend-etfs-to-watch-now?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/dgro-dvy-and-hdv-3-ishares-dividend-etfs-to-watch-now?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0157215616.USD","IE00BGHQF748.EUR","LU1064131342.USD","IE00B42XCP33.USD","LU1670628061.USD","LU2430703251.USD","DVY","BK4135","SCHD","LU1599440770.SGD","IE00BVYPNV92.GBP","LU2430703178.SGD","LU0320765489.SGD","LU0648001328.SGD","LU0731783394.SGD","BK4504","LU2505996681.GBP","IE00B64PRP62.GBP","LU1280957306.USD","LU1988902786.USD","LU2592432038.USD","LU2505996509.AUD","IE00B3PB1722.GBP","LU0772969993.USD","BK4534","LU0731783048.USD","LU1989771016.USD","LU1481011911.USD","BK4585","LU0640476718.USD","BK4581","BK4567","LU1201861249.SGD","LU1481011671.HKD","IE00BDGV0183.EUR","LU1291159041.SGD","HDV","LU0070302665.USD","BK4533","BK4535","IE00BGHQF631.EUR","LU1670627923.USD","IE00BVYPNW00.USD","LU1366333091.USD","DGRO","LU1509826696.USD","LU0980610538.SGD","IE00B3QW5Z07.USD","BLK","LU0130102774.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606209062","title":"Libevitug Approved in China as First-in-Class Hepatitis D Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2606209062","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606209062?lang=en_us&edition=fundamental","pubTime":"2026-01-27 16:15","pubTimestamp":1769501700,"startTime":"0","endTime":"0","summary":"BEIJING, Jan. 27, 2026 /PRNewswire/ -- Huahui Health announced that China's National Medical Products Administration  has granted conditional approval to its Libevitug injection for chronic hepatitis D virus  infection in adults with or without compensated cirrhosis. Libevitug is a human monoclonal antibody targeting the PreS1 domain of hepatitis B virus  and HDV envelope proteins, blocking viral entry into hepatocytes. As a groundbreaking advance in viral hepatitis care, it is China's first approved HDV therapy and a first-in-class antibody for viral hepatitis, addressing a critical clinical gap.According to the World Health Organization , HDV affects nearly 5%  of people with chronic HBV infection. HDV–HBV co-infection is considered the most severe form of chronic viral hepatitis due to more rapid progression towards hepatocellular carcinoma and liver-related death.","market":"sg","thumbnail":"https://mma.prnewswire.com/media/2870372/image1.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2870372/image1.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/libevitug-approved-in-china-as-first-in-class-hepatitis-d-treatment-302670977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4599","LU1878469433.USD","BK4585","HDV","BK4139","ALT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603635736","title":"Vir Biotechnology: Strengthening Best-in-Class HDV Profile with Robust SOLSTICE Data, Strategic Partnerships, and Sufficient Cash Runway Supporting Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2603635736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603635736?lang=en_us&edition=fundamental","pubTime":"2026-01-13 23:46","pubTimestamp":1768319170,"startTime":"0","endTime":"0","summary":"Patrick Trucchio, an analyst from H.C. Wainwright, reiterated the Buy rating on Vir Biotechnology. The associated price target remains the same wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/vir-biotechnology-strengthening-best-in-class-hdv-profile-with-robust-solstice-data-strategic-partnerships-and-sufficient-cash-runway-supporting-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/vir-biotechnology-strengthening-best-in-class-hdv-profile-with-robust-solstice-data-strategic-partnerships-and-sufficient-cash-runway-supporting-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HDV"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}